626-87-9 Usage
Chemical Properties
clear colorless to light yellow-brown liquid with a wine smell.
Uses
1,4-Dibromopentane is used in the preparation of pharaoh ant trail pheromone stereoisomer, indolizidine alkaloid. It is also involved in the preparation 1,2-dimethyl-1-phenylcyclopentane and boc-L-2-amino-6-bromoheptanoic acid.
Preparation
1,4-Dibromopentane is synthesized by ring-opening bromination of 2-methyltetrahydrofuran with hydrobromic acid and sulfuric acid. First, add hydrobromic acid into the reaction pot for cooling, slowly add 2-methyltetrahydrofuran and sulfuric acid in turn under stirring, and finish the addition when the temperature does not exceed 40°C. The temperature was raised to 60°C, reacted for 2h, and then reacted at 80-85°C for 4h. After cooling, the bromide was separated and washed with water until neutral to obtain 1,4-dibromopentane as an oily substance. Yield 92.5%.
Synthesis Reference(s)
Journal of the American Chemical Society, 74, p. 917, 1952 DOI: 10.1021/ja01124a016
Check Digit Verification of cas no
The CAS Registry Mumber 626-87-9 includes 6 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 3 digits, 6,2 and 6 respectively; the second part has 2 digits, 8 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 626-87:
(5*6)+(4*2)+(3*6)+(2*8)+(1*7)=79
79 % 10 = 9
So 626-87-9 is a valid CAS Registry Number.
InChI:InChI=1/C5H10Br2/c1-5(7)3-2-4-6/h5H,2-4H2,1H3/t5-/m1/s1
626-87-9Relevant articles and documents
Analine derivatives as OSC inhibitors
-
, (2008/06/13)
The present invention relates to compounds of formula (I) wherein U, Y, V, W, L, X, A1, A2, A3, A4, A5 and A6 are as defined in the description and claims and pharmaceutically acceptable salts and/or pharmaceutically acceptable esters thereof. The compounds are useful for the treatment and/or prophylaxis of diseases which are associated with 2,3-oxidosqualene-lanosterol cyclase such as hypercholesterolemia, hyperlipemia, arteriosclerosis, vascular diseases, mycoses, parasite infections, gallstones, tumors and/or hyperproliferative disorders, and/or treatment and/or prophylaxis of impaired glucose tolerance and diabetes.